Through the interrogation of 5,014 prostate cancer samples (Table 1), we found that FOXA1 alterations could be subdivided into three broad mutational mechanisms: missense mutations or in-frame indels, predicted truncating events, or gene amplifications. The gene discussed is FOXA1; the disease is Familial prostate cancer.